185 related articles for article (PubMed ID: 38267500)
21. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
[TBL] [Abstract][Full Text] [Related]
22. MiR-429 suppresses glioblastoma multiforme by targeting SOX2.
Dong H; Hao X; Cui B; Guo M
Cell Biochem Funct; 2017 Jul; 35(5):260-268. PubMed ID: 28749077
[TBL] [Abstract][Full Text] [Related]
23. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
[TBL] [Abstract][Full Text] [Related]
24. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
25. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
[TBL] [Abstract][Full Text] [Related]
26. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.
Xu Z; Zeng X; Xu J; Xu D; Li J; Jin H; Jiang G; Han X; Huang C
Neuro Oncol; 2016 Jun; 18(6):830-9. PubMed ID: 26681767
[TBL] [Abstract][Full Text] [Related]
27. DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells.
Chen B; McCuaig-Walton D; Tan S; Montgomery AP; Day BW; Kassiou M; Munoz L; Recasens A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924599
[TBL] [Abstract][Full Text] [Related]
28. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.
Sathyan P; Zinn PO; Marisetty AL; Liu B; Kamal MM; Singh SK; Bady P; Lu L; Wani KM; Veo BL; Gumin J; Kassem DH; Robinson F; Weng C; Baladandayuthapani V; Suki D; Colman H; Bhat KP; Sulman EP; Aldape K; Colen RR; Verhaak RG; Lu Z; Fuller GN; Huang S; Lang FF; Sawaya R; Hegi M; Majumder S
J Neurosci; 2015 Nov; 35(45):15097-112. PubMed ID: 26558781
[TBL] [Abstract][Full Text] [Related]
29. Essential role of METTL3-mediated m
Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
[TBL] [Abstract][Full Text] [Related]
30. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
[TBL] [Abstract][Full Text] [Related]
31. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.
Bageritz J; Puccio L; Piro RM; Hovestadt V; Phillips E; Pankert T; Lohr J; Herold-Mende C; Lichter P; Goidts V
Cell Death Differ; 2014 Jun; 21(6):929-40. PubMed ID: 24531536
[TBL] [Abstract][Full Text] [Related]
32. HES1 protein oscillations are necessary for neural stem cells to exit from quiescence.
Marinopoulou E; Biga V; Sabherwal N; Miller A; Desai J; Adamson AD; Papalopulu N
iScience; 2021 Oct; 24(10):103198. PubMed ID: 34703994
[TBL] [Abstract][Full Text] [Related]
33. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
34. SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma.
Guo M; Goudarzi KM; Abedi S; Pieber M; Sjöberg E; Behnan J; Zhang XM; Harris RA; Bartek J; Lindström MS; Nistér M; Hägerstrand D
Oncogene; 2021 Aug; 40(32):5066-5080. PubMed ID: 34021259
[TBL] [Abstract][Full Text] [Related]
35. The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single Cell Analysis.
Yan H; Zhu J; Ping Y; Yan M; Liao G; Yuan H; Zhou Y; Xiang F; Pang B; Xu J; Pang L
Stem Cells; 2023 Mar; 41(2):111-125. PubMed ID: 36583266
[TBL] [Abstract][Full Text] [Related]
36. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
37. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
[TBL] [Abstract][Full Text] [Related]
38. A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity.
Riddick G; Kotliarova S; Rodriguez V; Kim HS; Linkous A; Storaska AJ; Ahn S; Walling J; Belova G; Fine HA
Sci Rep; 2017 Mar; 7():43605. PubMed ID: 28256619
[TBL] [Abstract][Full Text] [Related]
39. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
40. New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells.
Kawamura Y; Takouda J; Yoshimoto K; Nakashima K
Cell Biol Toxicol; 2018 Dec; 34(6):425-440. PubMed ID: 29383547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
